⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ILMN News
Illumina Inc
Life Sciences Investment Opportunities Accelerate as AI and Genomics Drive $200+ Billion Market Expansion
globenewswire.com
ILMN
TMO
CRSP
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
prnewswire.com
ILMN
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
prnewswire.com
ILMN
AI Supercomputing Platform Market Research 2026-2032: Competition Intensifies as NVIDIA Leads While AMD, Intel and Hyperscalers Expand Custom Silicon Strategies
globenewswire.com
NVDA
AMD
INTC
HPE
DELL
MSFT
AMZN
GOOG
ORCL
SMCI
MU
META
TSM
BRO
CSCO
IBM
ARM
AMAT
LRCX
KLAC
QCOM
CRSP
REGN
GILD
BMY
MRNA
BIIB
EXAS
ILMN
VRTX
AZN
PFE
JNJ
AMGN
LLY
ABBV
BKR
XOM
CVX
NEE
DUK
SO
ED
PCG
SRE
AEP
WEC
ETR
NI
XEL
NRG
CEG
EIX
FE
D
CMS
PNW
ES
Form 8-K
sec.gov
ILMN
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
businesswire.com
TMO
ABBV
DHR
ILMN
NVO
QNRX
XBIO
David P. King elected to Illumina's Board of Directors
prnewswire.com
ILMN
Immuno Oncology Assay Market to Reach USD 21.49 Billion by 2036 Driven by Precision Cancer Diagnostics, Biomarker Testing, and Personalized Immunotherapy Advancements
accessnewswire.com
TMO
BIO
ILMN
QGEN
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
prnewswire.com
ILMN
Multiplex Assays Market worth $10.65 billion by 2031 | MarketsandMarkets™
prnewswire.com
TMO
ILMN
BIO
RIVN